Monoamine oxidase A gene DNA hypomethylation-a risk factor for panic disorder?

International Journal of Neuropsychopharmacology

Volumn 15, Issue 9, 2012, Pages 1217-1228

  Domschke, Katharina ^a,b   Tidow, Nicola ^a   Kuithan, Henriette ^a   Schwarte, Kathrin ^a   Klauke, Benedikt ^a,c   Ambrée, Oliver ^a   Reif, Andreas ^c   Schmidt, Hartmut ^a   Arolt, Volker ^a   Kersting, Anette ^d   Zwanzger, Peter ^a   Deckert, Jürgen ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Christoph Dornier Klinik for Psychotherapy   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Anxiety; epigenetics; gender; MAOA; methylation

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DNA;

ARTICLE; CPG ISLAND; DNA ISOLATION; DNA METHYLATION; DSM-IV; ENVIRONMENTAL FACTOR; EXON; FEMALE; GENETIC ASSOCIATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

ADULT; BASE SEQUENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA METHYLATION; EPIGENESIS, GENETIC; EXONS; FEMALE; HUMANS; LIFE CHANGE EVENTS; MALE; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; MONOAMINE OXIDASE; MUTAGENS; PANIC DISORDER; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; SULFITES;

EID: 84883491195     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571200020X     Document Type: Article

References (66)

1. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, et al. (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics 15, 3132-3145.
2. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, et al. (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients : a preliminary report. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 134, 60-66.
3. Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, et al. (2004). Methylomics in psychiatry: Modulation of geneenvironment interactions may be through DNA methylation. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 127, 51-59.
4. Brown GW, Harris T (1978). Social Origins of Depression : A Study of Psychiatric Disorder in Women. London: Tavistock.
5. Chaitidis P, Billett EE, O'Donnell VB, Fajardo AB, et al. (2004). Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A. Journal of Immunology 173, 4821-4827.
6. Dannlowski U, Ohrmann P, Konrad C, Domschke K, et al. (2009). Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. International Journal of Neuropsychopharmacology 12, 11-22.
7. Deckert J, Catalano M, Syagailo YV, Bosi M, et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics 8, 621-624.
8. Domschke K, Deckert J, O'Donovan M, Glatt SJ (2007). Meta-analysis of COMT val158met in panic disorder-ethnic heterogeneity and gender specificity. American Journal of Medical Genetics Neuropsychiatric Genetics 144, 667-673.
9. Domschke K, Hohoff C, Mortensen LS, Roehrs T, et al. (2008). Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression. Progress in Neuropsychopharmacology and Biological Psychiatry 32, 224-228.
10. Faravelli C (1985). Life events preceding the onset of panic disorder. Journal of Affective Disorders 9, 103-105.
11. Faravelli C, Pallanti S (1989). Recent life events and panic disorder. American Journal of Psychiatry 146, 622-626.
12. Farré D, Roset R, Huerta M, Adsuara JE, et al. (2003). Identification of patterns in biological sequences at the ALGGEN server : PROMO and MALGEN. Nucleic Acids Research 31, 3651-3653.
13. Fraga MF, Ballestar E, Paz MF, Ropero S, et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA 102, 10604-10409.
14. Gladkevich A, Kauffman HF, Korf J (2004). Lymphocytes as a neural probe: potential for studying psychiatric disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 28, 559-576.
15. Grayson DR, Jia X, Chen Y, Sharma RP, et al. (2005). Reelin promoter hypermethylation in schizophrenia. Proceedings of the National Academy of Sciences USA 102, 9341-9346.
16. Hamilton SP, Slager SL, Heiman GA, Haghighi F, et al. (2000). No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Molecular Psychiatry 5, 465-466.
17. Heberlein A, Muschler M, Frieling H, Behr M, et al. (2011). Epigenetic down regulation of nerve growth factor during alcohol withdrawal. Addiction Biology. Published online : 11 March 2011. doi:10.1111/j.1369-1600.2010.00307.x.
18. Hettema JM, Neale MC, Kendler KS (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry 158, 1568-1578.
19. Hillemacher T, Frieling H, Hartl T, Wilhelm J, et al. (2009). Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. Journal of Psychiatric Research 43, 388-392.
20. Holmes TH, Rahe RH (1967). The social readjustment rating scale. Journal of Psychosomatic Research 11, 213-218.
21. Hotamisligil GS, Breakefield XO (1991). Human monoamine oxidase A gene determines levels of enzyme activity. American Journal of Human Genetics 49, 383-392.
22. Jacob C, Domschke K, Gajewska A, Warrings B, et al. (2010). Genetics of panic disorder : focus on association studies and therapeutic perspectives. Expert Review of Neurotherapeutics 10, 1273-1284.
23. Jaenisch R, Bird A (2003). Epigenetic regulation of gene expression : how the genome integrates intrinsic and environmental signals. Nature Genetics 33, 245-254.
24. Jang KL, Stein MB, Taylor S, Livesley WJ (1999). Gender differences in the etiology of anxiety sensitivity: a twin study. Journal of Gender Specific Medicine 2, 39-44.
25. Jorm AF, Henderson AS, Jacomb PA, Christensen H, et al. (2000). Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatric Genetics 10, 87-90.
26. Kersting A, Kroker K, Horstmann J, Baune BT, et al. (2007). Association of MAO-A variant with complicated grief in major depression. Neuropsychobiology 56, 191-196.
27. Klauke B, Deckert J, Reif A, Pauli P, et al. (2010). Life events in panic disorder-an update on 'candidate stressors'. Depression and Anxiety 27, 716-730.
28. Launay JM, Del Pino M, Chironi G, Callebert J, et al. (2009). Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 4, 7959.
29. Lewin J, Schmitt AO, Adorján P, Hildmann T, et al. (2004). Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20, 3005-3012.
30. Maron E, Lang A, Tasa G, Liivlaid L, et al. (2005). Associations between serotonin-related gene polymorphisms and panic disorder. International Journal of Neuropsychopharmacology 8, 261-266.
31. Maron E, Tõru I, Hirvonen J, Tuominen L, et al. (2011). Gender differences in brain serotonin transporter availability in panic disorder. Journal of Psychopharmacology 25, 952-959.
32. Melas PA, Rogdaki M, Lennartsson A, Björk K, et al. (in press). Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. International Journal of Neuropsychopharmacology. Published online : 20 June 2011. doi :10.1017/S1461145711000940.
33. Messeguer X, Escudero R, Farré D, Nuñ ez O, et al. (2002). PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334.
34. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, et al. (2006). Elevated monoamine oxidase a levels in the brain : an explanation for the monoamine imbalance of major depression. Archives of General Psychiatry 63, 1209-1216.
35. Mill J, Petronis A (2007). Molecular studies of major depressive disorder: the epigenetic perspective. Molecular Psychiatry 12, 799-814.
36. Mill J, Tang T, Kaminsky Z, Khare T, et al. (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American Journal of Human Genetics 82, 696-711.
37. Murphy BC, O'Reilly RL, Singh SM (2005). Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. American Journal of Medical Genetics Neuropsychiatric Genetics 133, 37-42.
38. Muschler MA, Hillemacher T, Kraus C, Kornhuber J, et al. (2010). DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. Journal of Neural Transmission 117, 513-519.
39. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, et al. (2011). DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. Journal of Psychiatric Research 45, 1432-1438.
40. Ohrmann P, Pedersen A, Braun M, Bauer J, et al. (2010). Effect of gender on processing threat-related stimuli in patients with panic disorder : sex does matter. Depression and Anxiety 27, 1034-1043.
41. Paykel ES, Prusoff BA, Myers JK (1975). Suicide attempts and recent life events. A controlled comparison. Archives of General Psychiatry 32, 327-333.
42. Philibert R, Madan A, Andersen A, Cadoret R, et al. (2007a). Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. American Journal of Medical Genetics Neuropsychiatric Genetics 144, 101-105.
43. Philibert RA, Beach SR, Gunter TD, Brody GH, et al. (2010). The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. American Journal of Medical Genetics Neuropsychiatric Genetics 153, 619-628.
44. Philibert RA, Crowe R, Ryu GY, Yoon JG, et al. (2007b). Transcriptional profiling of lymphoblast lines from subjects with panic disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144, 674-682.
45. Philibert RA, Gunter TD, Beach SR, Brody GH, et al. (2008a). MAOA methylation is associated with nicotine and alcohol dependence in women. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147, 565-570.
46. Philibert RA, Ryu GY, Yoon JG, Sandhu H, et al. (2007c). Transcriptional profiling of subjects from the Iowa adoption studies. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 144, 683-690.
47. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, et al. (2008b). The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 147, 543-549.
48. Pinsonneault JK, Papp AC, Sadée W (2006). Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain : dissection of epigenetic and genetic factors. Human Molecular Genetics 15, 2636-2649.
49. Politi E, Balduzzi C, Bussi R, Bellodi L (1999). Artificial neural networks: a study in clinical psychopharmacology. Psychiatry Research 87, 203-215.
50. Rahe RH (1979). Life change events and mental illness : an overview. Journal of Human Stress 5, 2-10.
51. Ravindran LN, Stein MB (2010). The pharmacologic treatment of anxiety disorders : a review of progress. Journal of Clinical Psychiatry 71, 839-854.
52. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics 103, 273-279.
53. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, et al. (2004). Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research 128, 21-26.
54. Shih JC, Chen K (1999). MAO-A and-B gene knock-out mice exhibit distinctly different behavior. Neurobiology 7, 235-246.
55. Shumay E, Fowler JS (2010). Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches. Epigenetics 5, 325-342.
56. Syagailo YV, Stöber G, Grässle M, Reimer E, et al. (2001). Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. American Journal of Genetics 105, 168-171.
57. Szyf M, McGowan P, Meaney MJ (2008). The social environment and the epigenome. Environmental and Molecular Mutagenesis 49, 46-60.
58. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, et al. (2011). DNA methylation in white blood cells-association with risk factors in epidemiologic studies. Epigenetics 6, 828-837.
59. Tiller JW, Bouwer C, Behnke K (1997). Moclobemide for anxiety disorders : a focus on moclobemide for panic disorder. International Clinical Psychopharmacology 6, 27-30.
60. Thorpe LW, Westlund KN, Kochersperger LM, Abell CW, et al. (1987). Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. Journal of Histochemistry and Cytochemistry 35, 23-32.
61. Wang Y, Neumann M, Hansen K, Hong SM, et al. (2011). Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. Journal of Neurotrauma 28, 259-268.
62. Weissman MM, Bland RC, Canino GJ, Faravelli C, et al. (1997). The cross-national epidemiology of panic disorder. Archives of General Psychiatry 54, 305-309.
63. Wittchen HU (1997). SKID-I: strukturiertes klinisches Interview fü r DSM-IV, Achse I : Psychische Störungen. Goettingen: Hogrefe.
64. Wong CC, Caspi A, Williams B, Craig IW, et al. (2010). A longitudinal study of epigenetic variation in twins. Epigenetics 5, 516-526.
65. Yeaworth RC, McNamee MJ, Pozehl B (1992). The Adolescent Life Change Event Scale : its development and use. Adolescence 27, 783-802.
66. Zhubi A, Veldic M, Puri NV, Kadriu B, et al. (2009). An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophrenia Research 111, 115-122.